Home » People » Gürsel Çalışkan, Ph.D.

Gürsel Çalışkan, Ph.D.

gursel

I am a postdoctoral researcher since August-2014 in our research group. I am interested in combining different approaches including electrophysiology, behavior and pharmacogenetics to tackle some of the challenging and exciting questions in stress- and fear-related research field. Specifically, my current project deals with the state-dependent role of parvalbumin-positive interneurons in fear memory (re)-consolidation in relation to network activity modulation in the ventral hippocampus.

Education
B.Sc. in Molecular Biology and Genetics, Istanbul Technical University, Istanbul, Turkey 2006
M.Sc. in Medical Neurosciences, Humboldt University, Charité Medical Faculty, Berlin, Germany 2008
Ph.D. in Medical Neurosciences, Humboldt University, Charité Medical Faculty, Berlin, Germany 2015

Contact information
E-mail: guersel.caliskan[at]ovgu.de
Telephone: +49(391)-67 55108


Publications

Klaft Z, Hollnagel J, Salar S, Çalışkan G, Schulz SB, Schneider UC, Horn P, Koch A, Holtkamp M, Gabriel S, Gerevich Z, Heinemann U. Adenosine A1 receptor–mediated suppression of carbamazepine-resistant seizure-like events in human neocortical slices. Epilepsia. 2016, 57: 746–756.

Albrecht A, Ivens S, Papageorgiou IE, Çalışkan G, Saiepour N, Brück W, Richter-Levin G, Heinemann U, Stork O. Shifts in excitatory/inhibitory balance by juvenile stress: A role for neuron-astrocyte interaction in the dentate gyrus. Glia. 2016 Jun;64(6):911-22.

Çalışkan G, Müller I, Semtner M, Winkelmann A, Raza AS, Hollnagel JO, Rösler A, Heinemann U, Stork O, Meier JC. Identification of Parvalbumin Interneurons as Cellular Substrate of Fear Memory Persistence. Cereb Cortex. 2016 May;26(5):2325-40.

Gruber D, Gilling K, Albrecht A, Bartsch JC, Çalışkan G, Richter-Levin G, Stork O, Heinemann U, Behr J. 5-HT receptor-mediated modulation of granule cell inhibition after stress recovers after a second exposure to stress in adulthood. Neuroscience. 2015 293: 67–79.

Çalışkan G, Albrecht A*, Hollnagel JO, Rösler A, Richter-Levin G, Heinemann U, Stork O. Long-term changes in the CA3 associative network of fear-conditioned mice. Stress. 2015 Jan 30:1-10. (* Equal Contribution)

Çalışkan G, Schulz SB, Gruber D, Behr J, Heinemann U, Gerevich Z. Corticosterone and corticotropin-releasing factor acutely facilitate gamma oscillations in the hippocampus in vitro. Eur J Neurosci. 2015 Jan;41(1):31-44.

Müller I, Çalışkan G, Stork O. The GAD65 knock out mouse – a model for GABAergic processes in fear- and stress-induced psychopathology. Genes Brain Behav. 2015 Jan;14(1):37-45.

Winkelmann A, Maggio N, Eller J, Çalışkan G, Semtner M, Häussler U, Jüttner R, Dugladze T, Smolinsky B, Kowalczyk S, Chronowska E, Schwarz G, Rathjen FG, Rechavi G, Haas CA, Kulik A, Gloveli T, Heinemann U, Meier JC. Changes in neural network homeostasis trigger neuropsychiatric symptoms. J Clin Invest. 2014 Feb;124(2):696-711.

Çalışkan G, Albrecht A. Noradrenergic interactions via autonomic nervous system: a promising target for extinction-based exposure therapy? J Neurophysiol. 2013 Dec;110(11):2507-10.

Albrecht A*, Çalışkan G*, Oitzl MS, Heinemann U, Stork O. Long-lasting increase of corticosterone after fear memory reactivation: anxiolytic effects and network activity modulation in the ventral hippocampus. Neuropsychopharmacology. 2013 Feb;38(3):386-94. (* Equal Contribution)

Fano S*, Çalışkan G*, Heinemann U. Differential effects of blockade of ERG channels on gamma oscillations and excitability in rat hippocampal slices. Eur J Neurosci. 2012 Dec;36(12):3628-35. (* Equal Contribution)

Fano S, Çalışkan G, Behrens CJ, Heinemann U. Histaminergic modulation of acetylcholine-induced γ oscillations in rat hippocampus. Neuroreport. 2011 Aug 3;22(11):520-4.

Liotta A*, Çalışkan G*, ul Haq R, Hollnagel JO, Rösler A, Heinemann U, Behrens CJ. Partial disinhibition is required for transition of stimulus-induced sharp wave-ripple complexes into recurrent epileptiform discharges in rat hippocampal slices. J Neurophysiol. 2011 Jan;105(1):172-87. (* Equal Contribution)